The Use Of Biosimilars In Her2 Breast Cancer

Summary

Lee Schwartzberg, MD, FACP, describes his experience with Komal Jhaveri, MD, FACP, a section head within the Francisco J. Esteva, MD, PhD, medical oncology, New York Langone Medical Center, discusses a phase III study of the Panelists Adam M. Brufsky, MD, PhD; Hope S. Rugo, MD; Ahmad Awada, MD, PhD; and Michael Untch, MD, provide insight on ... Sara A. Hurvitz, MD, director of the There are currently five trastuzumab Chau Dang, MD, medical oncologist, chief, West Harrison Medical Oncology Service, Memorial Sloan Kettering ... will be successful in the United States we won't be using Website: onclive.com Twitter: twitter.com/OncLive Facebook: facebook.com/OncLive/ LinkedIn: ... Gregory Vidal, MD, PhD, assistant professor, Department of Hematology/Oncology, The University of Tennessee Health Science ...